Red Paper
Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Pharmacology and Clinical Research
Peer Reviewed Journal

Vol. 8, Issue 1, Part A (2026)

Molecular docking study of phyllanthus Amarus Metabolites: A potential alternative therapy for Hepatitis B

Author(s):

Siva Nageswara Rao Mekala, Ali Said Yussuf, Saravanan R, Anand Paramasivam, Arul Amuthan and Murugesan Annamalai

Abstract:

Hepatitis B (HB) is a major viral infection that endangers millions of people worldwide and traditional interventions such as Tenofovir have proven to be restrictive. Phytomedicine The traditional plant Phytanthus amarus is a wellknown antiviral (especially anti-HBV). It is a molecular docking study that assesses Phyllanthin, a bioactive product obtained in Phyllanthus Marus and tenofovir in the determination of their binding affinities to the core protein of Hepatitis B virus (PDB ID: 5WRE). The findings revealed that Phyllanthin has a MolDock score of -101.92, which is much lower than -86.87 that of Tenofovir, which means that it has a higher binding affinity. The hydrogen bond analysis demonstrated that the weaker bonds of Phyllanthin were compensated with the greater specificity and stability and it is a good candidate to be experimentally validated. These results indicate that Phyllanthin may be a successful alternative/ adjunct to traditional antiviral management of Hepatitis B.

Pages: 01-06  |  73 Views  28 Downloads


International Journal of Pharmacology and Clinical Research
How to cite this article:
Siva Nageswara Rao Mekala, Ali Said Yussuf, Saravanan R, Anand Paramasivam, Arul Amuthan and Murugesan Annamalai. Molecular docking study of phyllanthus Amarus Metabolites: A potential alternative therapy for Hepatitis B. Int. J. Pharmacol. Clin. Res. 2026;8(1):01-06. DOI: 10.33545/26647613.2026.v8.i1a.167
Call for book chapter